Showing 4281-4290 of 6036 results for "".
- Research Unveils Potential Breakthrough in Diabetic Retinopathy Treatmenthttps://modernod.com/news/research-unveils-potential-breakthrough-in-diabetic-retinopathy-treatment/2481962/Researchers from Washington University in St. Louis have discovered a potential new treatment approach to diabetic retinopathy. Diabetic retinopathy’s enigma unfolds with the role of microglia, immune cells resident in the retina. When confronted with high blood glucose levels, th
- First Patient Dosed in Ocugen's Phase 1/2 Trial Evaluating Safety and Efficacy of OCU41OST Modifier Gene Therapy for Stargardt Diseasehttps://modernod.com/news/first-patient-dosed-in-ocugens-phase-12-trial-evaluating-safety-and-efficacy-of-ocu41ost-modifier-gene-therapy-for-stargardt-disease/2481960/Ocugen announced that the first patient has been dosed in its phase 1/2 GARDian clinical trial for OCU410ST (AAV5-hRORA)—a modifier gene therapy candidate being developed for Stargardt disease. “There is a significant unmet medical need for the approximate 35,000 patien
- Outlook Therapeutics Provides Update on Type A Meetings with FDA for Wet AMD Product Candidatehttps://modernod.com/news/outlook-therapeutics-provides-update-on-type-a-meetings-with-fda-for-wet-amd-product-candidate/2481959/Outlook Therapeutics announced that it has completed the requested Type A Meetings with the FDA to discuss the complete response letter (CRL) dated August 29, 2023 regarding the biologics license application (BLA) for ONS-5010, an investigational ophthalmi
- World’s First Whole Eye & Partial Face Transplant Performed at NYU Langone Healthhttps://modernod.com/news/worlds-first-whole-eye-partial-face-transplant-performed-at-nyu-langone-health/2481958/A surgical team from NYU Langone Health performed the world’s first whole-eye and partial-face transplant for a 46-year-old military veteran from Arkansas who survived a work-related high-voltage electrical accident. The surgery included transplanting the entire left eye and a portion of th
- Visionix Announces Strategic Partnership with 20/20NOWhttps://modernod.com/news/visionix-announces-strategic-partnership-with-2020now/2481957/Visionix USA announced it has entered a into a strategic alliance with 20/20NOW with the aim of bringing cost-effective, in-office, synchronous tele-optometry eye exams and ocular telemedicine closer to more patients throughout the United States. Financial terms of the deal we
- ASCRS Names Abigail Markward New Executive Directorhttps://modernod.com/news/ascrs-names-abigail-markward-new-executive-director/2481952/The American Society of Cataract and Refractive Surgery (ASCRS) has named Abigail Markward as the new Executive Director of the ASCRS Foundation. Ms. Markward has more than two decades of expertise in strategic communications, marketing, publishing, and nonprofit roles. Most recent
- IRIS Registry-based Study Evaluates Side-Effect of Semaglutide Weight-Loss Drug on Diabetic Retinopathyhttps://modernod.com/news/iris-registry-based-study-evaluates-side-effect-of-semaglutide-weight-loss-drug-on-diabetic-retinopathy/2481947/According to the American Academy of Ophthalmology (AAO), new review of real-world data offers reassurance for the use of the diabetes drug semaglutide, which is popular for helping people lower their glucose levels and better manage their weight. At issue has been that a potential side effect of
- Kiora’s KIO-301 Molecular Photoswitch Evaluated for Retinitis Pigmentosa in ABACUShttps://modernod.com/news/kioras-kio-301-molecular-photoswitch-evaluated-for-retinitis-pigmentosa-in-abacus/2481946/Kiora Pharmaceuticals announced topline results of a phase 1/2 clinical trial demonstrating proof-of-concept that KIO-301, the company’s first-in-class intravitreal (IVT) molecular photoswitch, has the potential to meaningfully improve vision in patients with retinitis pigmentosa (RP)
- Topcon Introduces Tempo Perimeter at AAO 2023https://modernod.com/news/topcon-introduces-tempo-perimeter-at-aao-2023/2481942/Topcon announced that it is launching the Tempo Perimeter at the American Academy of Ophthalmology (AAO) meeting in San Francisco. Tempo is designed to provides fast, accurate, and comfortable visual field testing, according to Topcon. It is 39% faster than Stan
- Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websiteshttps://modernod.com/news/ace-vision-group-adds-four-ophthalmologists-to-medical-advisory-board-launches-new-corporate-and-medical-affairs-websites/2481941/Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for e